NO173988C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater

Info

Publication number
NO173988C
NO173988C NO900417A NO900417A NO173988C NO 173988 C NO173988 C NO 173988C NO 900417 A NO900417 A NO 900417A NO 900417 A NO900417 A NO 900417A NO 173988 C NO173988 C NO 173988C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous procedures
pyrrolidine derivatives
active pyrrolidine
Prior art date
Application number
NO900417A
Other languages
English (en)
Norwegian (no)
Other versions
NO173988B (no
NO900417L (no
NO900417D0 (no
Inventor
Motosuke Yamanaka
Tomonori Hoshiko
Shinji Suda
Naoki Yoneda
Nobuyuki Mori
Mitsumasa Shina
Hiroki Ishihara
Mamoru Saito
Toshiyuki Matsuoka
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1254349A external-priority patent/JP2928288B2/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO900417D0 publication Critical patent/NO900417D0/no
Publication of NO900417L publication Critical patent/NO900417L/no
Publication of NO173988B publication Critical patent/NO173988B/no
Publication of NO173988C publication Critical patent/NO173988C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO900417A 1989-02-03 1990-01-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater NO173988C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2526289 1989-02-03
JP1254349A JP2928288B2 (ja) 1989-09-29 1989-09-29 ピロリジン誘導体

Publications (4)

Publication Number Publication Date
NO900417D0 NO900417D0 (no) 1990-01-30
NO900417L NO900417L (no) 1990-08-06
NO173988B NO173988B (no) 1993-11-22
NO173988C true NO173988C (no) 1994-03-02

Family

ID=26362859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900417A NO173988C (no) 1989-02-03 1990-01-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater

Country Status (15)

Country Link
US (1) US5444083A (de)
EP (1) EP0381235B1 (de)
KR (1) KR920003892B1 (de)
CN (1) CN1044652A (de)
AT (1) ATE92043T1 (de)
CA (1) CA2009162A1 (de)
DE (1) DE69002338T2 (de)
DK (1) DK0381235T3 (de)
ES (1) ES2058620T3 (de)
FI (1) FI900353A7 (de)
HU (1) HUT53867A (de)
NO (1) NO173988C (de)
NZ (1) NZ232334A (de)
PT (1) PT93045A (de)
RU (1) RU2024506C1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015205A1 (en) * 1990-04-06 1991-10-17 Eisai Co., Ltd. Solid oral preparation containing catechol compound
WO1992018475A2 (en) * 1991-04-17 1992-10-29 The Upjohn Company Substituted phenylazacycloalkanes as cns agents
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
DE69630214T2 (de) * 1995-03-10 2004-07-15 Berlex Laboratories, Inc., Richmond Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
US6294561B1 (en) * 1999-12-23 2001-09-25 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US6514226B1 (en) * 2000-02-10 2003-02-04 Chf Solutions, Inc. Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
DE10257356A1 (de) * 2002-12-09 2004-06-24 Bayer Ag Fluorhaltige Aromaten
AU2008258599B2 (en) * 2007-06-05 2013-06-13 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
CN103012175A (zh) * 2012-12-21 2013-04-03 东南大学 抗肿瘤含氮取代基姜黄素类似物、其盐及制备方法
CN118084757B (zh) * 2023-10-10 2025-09-16 广东药科大学 2个内酰胺类物质及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852526A (en) * 1955-05-03 1958-09-16 Schering Corp Substituted pyrrolidines
AT232503B (de) * 1962-03-05 1964-03-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen 3-Phenyl-pyrrolidinen und deren Salzen
FR2460929A1 (fr) * 1979-07-06 1981-01-30 Roussel Uclaf Nouveaux derives de l'a-phenyl 2-pyrrolidinemethanol et leur sels, procede de preparation, application a titre de medicaments et compositions les renfermant
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives

Also Published As

Publication number Publication date
FI900353A0 (fi) 1990-01-23
PT93045A (pt) 1990-08-31
EP0381235A3 (de) 1991-04-03
NO173988B (no) 1993-11-22
DE69002338D1 (de) 1993-09-02
EP0381235B1 (de) 1993-07-28
ATE92043T1 (de) 1993-08-15
NO900417L (no) 1990-08-06
RU2024506C1 (ru) 1994-12-15
US5444083A (en) 1995-08-22
HU900654D0 (en) 1990-04-28
KR920003892B1 (ko) 1992-05-18
ES2058620T3 (es) 1994-11-01
NZ232334A (en) 1991-06-25
DK0381235T3 (da) 1993-10-04
CA2009162A1 (en) 1990-08-03
DE69002338T2 (de) 1993-12-16
HUT53867A (en) 1990-12-28
EP0381235A2 (de) 1990-08-08
FI900353A7 (fi) 1990-08-04
AU4901390A (en) 1990-11-01
CN1044652A (zh) 1990-08-15
AU619943B2 (en) 1992-02-06
KR900012903A (ko) 1990-09-03
NO900417D0 (no) 1990-01-30

Similar Documents

Publication Publication Date Title
NO976085L (no) Difenylmetylen-piperidin-derivater
NO932442L (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved behandling av hepatitt b
FI891980A0 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
MX9306831A (es) Nuevos compuestos heterociclicos.
NO173988C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
PT958280E (pt) Derivados de arilpiperidinopropanol e arilpiperazinopropanol e farmacos contendo os mesmos
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
AU645090B2 (en) Novel N-Benzyl-N-Phenyl and -Phenalkyl-Thioureas
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
NO914734D0 (no) 5-amino-5,6,7,8-tetrahydrokinoliner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.